buformin has been researched along with Diabetic Coma in 1 studies
Buformin: An oral hypoglycemic agent that inhibits gluconeogenesis, increases glycolysis, and decreases glucose oxidation.
buformin : A member of the class of biguanides that is biguanide substituted by a butyl group at position 1. It is an antidiabetic drug with potential antitumor effect.
Diabetic Coma: A state of unconsciousness as a complication of diabetes mellitus. It occurs in cases of extreme HYPERGLYCEMIA or extreme HYPOGLYCEMIA as a complication of INSULIN therapy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clavadetscher, P | 1 |
| Bischof, P | 1 |
| Wegmann, T | 1 |
1 other study available for buformin and Diabetic Coma
| Article | Year |
|---|---|
[Lactic acidosis after administration of buformine (author's transl)].
Topics: Acidosis; Aged; Bicarbonates; Biguanides; Buformin; Diabetes Mellitus; Diabetic Coma; Female; Humans | 1976 |